跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL PAPAVERINE HYDROCHLORIDE 120mg/10mL Injection - TGA Drug Approval Details
Approvals
/
TGA
/
DBL PAPAVERINE HYDROCHLORIDE 120mg/10mL Injection
Approved
STANDARD
DBL PAPAVERINE HYDROCHLORIDE 120mg/10mL Injection
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2cef89ebc9ff5025
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
2cef89ebc9ff5025
Product Name
DBL PAPAVERINE HYDROCHLORIDE 120mg/10mL Injection
Artg Id
16277
Artg Name
DBL PAPAVERINE HYDROCHLORIDE 120mg/10mL injection ampoule
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1991-10-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-01870-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-01869-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2cef89ebc9ff5025
Type
Standard
Back to TGA Approvals